Company News For Apr 8, 2019

Zacks Equity Research Published on April 08, 2019

The Boeing Co.’s (BA - Free Report) shares declined 1% following the company’s decision to cut its monthly 737 aircraft production by nearly 20%
Shares of ABIOMED Inc. gained 0.7% following news that its flagship drug Impella significantly improved survival rate of cardiogenic shock and heart recovery
Triumph Group, Inc. (TGI - Free Report) shares jumped 12.3% after it revealed that it has hired Citigroup Inc. (C - Free Report) to explore strategic alternatives for its aerospace structures business
Shares of Johnson & Johnson (JNJ - Free Report) increased 0.5% after Oklahoma's attorney general has dropped all but one claim against the company related to allegations of spreading the opioid epidemic

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.